Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction
Open Access
- 9 October 2009
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 28 (1) , 3-8
Abstract
Purpose Previous studies on associations between voiding dysfunction and quality of life (QoL) have largely been limited to baseline data. Therefore, we have explored associations between Q max and voiding and storage sub-scores of the International Prostate Symptom Score (IPSS) before and after treatment with QoL. Methods Analysis of a single-center database of 2,316 men with voiding dysfunction attributed to benign prostatic hyperplasia undergoing various medical and surgical treatment forms. Results Qmax exhibited little correlation with QoL before or after treatment. IPSS inversely correlated with QoL at baseline and after treatment, and IPSS improvements correlated with those of QoL. The associations applied to both the voiding and storage sub-score of the IPSS, with the latter consistently exhibiting somewhat tighter associations. Conclusions Our post-treatment data support the idea of a cause–effect relationship between voiding symptoms and QoL irrespective of treatment form. While both voiding and storage symptoms contribute to this relationship, storage symptoms play a somewhat greater role.Keywords
This publication has 29 references indexed in Scilit:
- The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health‐related quality of life, anxiety and depression: EpiLUTSBJU International, 2009
- Implications of recent epidemiology studies for the clinical management of lower urinary tract symptomsBJU International, 2009
- Differential Impact of Lower Urinary Tract Symptoms on Generic and Disease-Specific Quality of Life in Men and WomenUrologia Internationalis, 2008
- The Relation of Lower Urinary Tract Symptoms with Life-Style Factors and Objective Measures of Benign Prostatic Enlargement and Obstruction: An Italian SurveyEuropean Urology, 2004
- Quality-of-Life Assessment in Patients with Benign Prostatic HyperplasiaPharmacoEconomics, 2001
- Clinical comparison of selective and non‐selective &agr; 1 A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing dosesBritish Journal of Urology, 1997
- Correlation Between the International Prostatic Symptom Score and a Pressure-Flow Study in the Evaluation of Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1996
- Correlation Between the International Prostatic Symptom Score and a Pressure-Flow Study in the Evaluation of Symptomatic Benign Prostatic HyperplasiaJournal of Urology, 1996
- Correlation of American Urological Association Symptom Index With Obstructive and Nonobstructive ProstatismJournal of Urology, 1995
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995